EMEA (Europe, Middle East and Africa) Paclitaxel Market 2017 Forecast to 2022

Publisher Name :
Date: 15-Jan-2018
No. of pages: 123

Paclitaxel is a mitotic inhibitor used in cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Scope of the Report:

This report focuses on the Paclitaxel in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

  • Phyton

  • ScinoPharm

  • Novasep

  • Samyang

  • Polymed

  • TAPI (Teva)

  • Fresenius-kabi

  • Southpharma

  • Haiyao

  • Huiang biopharma

  • Yunnan Hande

  • Hainan Yew Pharm

Market Segment by Regions, regional analysis covers

  • Europe (Germany, France, UK, Russia, Italy and Turkey)

  • Middle East (Saudi Arabia, Israel, UAE and Iran)

  • Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

  • Natural Paclitaxel

  • Semi-synthetic Paclitaxel

Market Segment by Applications, can be divided into

  • Ovarian Cancer

  • Cervical Cancer

  • Breast Cancer

  • Other

There are 13 Chapters to deeply display the EMEA Paclitaxel market.

Chapter 1, to describe Paclitaxel Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Paclitaxel, with sales, revenue, and price of Paclitaxel, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Paclitaxel, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Paclitaxel market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Paclitaxel research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

EMEA (Europe, Middle East and Africa) Paclitaxel Market 2017 Forecast to 2022

Table of Contents

1 Market Overview
1.1 Paclitaxel Introduction
1.2 Market Analysis by Type
1.2.1 Natural Paclitaxel
1.2.2 Semi-synthetic Paclitaxel
1.3 Market Analysis by Applications
1.3.1 Ovarian Cancer
1.3.2 Cervical Cancer
1.3.3 Breast Cancer
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
1.4.1.1 Germany Market States and Outlook (2012-2022)
1.4.1.2 France Market States and Outlook (2012-2022)
1.4.1.3 UK Market States and Outlook (2012-2022)
1.4.1.4 Italy Market States and Outlook (2012-2022)
1.4.1.5 Russia Market States and Outlook (2012-2022)
1.4.1.6 Turkey Market States and Outlook (2012-2022)
1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
1.4.2.2 UAE Market States and Outlook (2012-2022)
1.4.2.3 Israel Market States and Outlook (2012-2022)
1.4.2.4 Iran Market States and Outlook (2012-2022)
1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
1.4.3.1 South Africa Market States and Outlook (2012-2022)
1.4.3.2 Nigeria Market States and Outlook (2012-2022)
1.4.3.3 Egypt Market States and Outlook (2012-2022)
1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 Phyton
2.1.1 Business Overview
2.1.2 Paclitaxel Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ScinoPharm
2.2.1 Business Overview
2.2.2 Paclitaxel Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Novasep
2.3.1 Business Overview
2.3.2 Paclitaxel Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Samyang
2.4.1 Business Overview
2.4.2 Paclitaxel Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Polymed
2.5.1 Business Overview
2.5.2 Paclitaxel Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 TAPI (Teva)
2.6.1 Business Overview
2.6.2 Paclitaxel Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Fresenius-kabi
2.7.1 Business Overview
2.7.2 Paclitaxel Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Southpharma
2.8.1 Business Overview
2.8.2 Paclitaxel Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Haiyao
2.9.1 Business Overview
2.9.2 Paclitaxel Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Haiyao Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Huiang biopharma
2.10.1 Business Overview
2.10.2 Paclitaxel Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Yunnan Hande
2.11.1 Business Overview
2.11.2 Paclitaxel Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hainan Yew Pharm
2.12.1 Business Overview
2.12.2 Paclitaxel Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 EMEA Paclitaxel Market Competition, by Manufacturer
3.1 EMEA Paclitaxel Sales and Market Share by Manufacturer
3.2 EMEA Paclitaxel Revenue and Market Share by Manufacturer
3.3 EMEA Paclitaxel Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Paclitaxel Manufacturer Market Share
3.4.2 Top 5 Paclitaxel Manufacturer Market Share
3.5 Market Competition Trend

4 EMEA Paclitaxel Market Analysis by Regions
4.1 EMEA Paclitaxel Sales, Revenue and Market Share by Regions
4.1.1 EMEA Paclitaxel Sales by Regions (2012-2017)
4.1.2 EMEA Paclitaxel Revenue by Regions (2012-2017)
4.2 Europe Paclitaxel Sales and Growth (2012-2017)
4.3 Middle East Paclitaxel Sales and Growth (2012-2017)
4.4 Africa Paclitaxel Sales and Growth (2012-2017)

5 Europe Paclitaxel by Countries, Type, Application and Manufacturers
5.1 Europe Paclitaxel Sales, Revenue and Market Share by Countries
5.1.1 Europe Paclitaxel Sales by Countries (2012-2017)
5.1.2 Europe Paclitaxel Revenue by Countries (2012-2017)
5.1.3 Germany Paclitaxel Sales and Growth (2012-2017)
5.1.4 France Paclitaxel Sales and Growth (2012-2017)
5.1.5 UK Paclitaxel Sales and Growth (2012-2017)
5.1.6 Russia Paclitaxel Sales and Growth (2012-2017)
5.1.7 Italy Paclitaxel Sales and Growth (2012-2017)
5.1.8 Turkey Paclitaxel Sales and Growth (2012-2017)
5.2 Europe Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 Europe Paclitaxel Sales by Manufacturers (2016-2017)
5.2.2 Europe Paclitaxel Revenue by Manufacturers (2016-2017)
5.3 Europe Paclitaxel Sales by Type (2012-2017)
5.4 Europe Paclitaxel Sales by Application (2012-2017)

6 Middle East Paclitaxel by Countries, Type, Application and Manufacturers
6.1 Middle East Paclitaxel Sales, Revenue and Market Share by Countries
6.1.1 Middle East Paclitaxel Sales by Countries (2012-2017)
6.1.2 Middle East Paclitaxel Revenue by Countries (2012-2017)
6.1.3 Saudi Arabia Paclitaxel Sales and Growth (2012-2017)
6.1.4 Israel Paclitaxel Sales and Growth (2012-2017)
6.1.5 UAE Paclitaxel Sales and Growth (2012-2017)
6.1.6 Iran Paclitaxel Sales and Growth (2012-2017)
6.2 Middle East Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Middle East Paclitaxel Sales by Manufacturers (2016-2017)
6.2.2 Middle East Paclitaxel Revenue by Manufacturers (2016-2017)
6.3 Middle East Paclitaxel Sales by Type (2012-2017)
6.4 Middle East Paclitaxel Sales by Application (2012-2017)

7 Africa Paclitaxel by Countries, Type, Application and Manufacturers
7.1 Africa Paclitaxel Sales, Revenue and Market Share by Countries
7.1.1 Africa Paclitaxel Sales by Countries (2012-2017)
7.1.2 Africa Paclitaxel Revenue by Countries (2012-2017)
7.1.3 South Africa Paclitaxel Sales and Growth (2012-2017)
7.1.4 Nigeria Paclitaxel Sales and Growth (2012-2017)
7.1.5 Egypt Paclitaxel Sales and Growth (2012-2017)
7.1.6 Algeria Paclitaxel Sales and Growth (2012-2017)
7.2 Middle East Paclitaxel Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Middle East Paclitaxel Sales by Manufacturers (2016-2017)
7.2.2 Middle East Paclitaxel Revenue by Manufacturers (2016-2017)
7.3 Middle East Paclitaxel Sales by Type (2012-2017)
7.4 Middle East Paclitaxel Sales by Application (2012-2017)

8 EMEA Paclitaxel Market Segment by Type
8.1 EMEA Paclitaxel Sales, Revenue and Market Share by Type (2012-2017)
8.1.1 EMEA Paclitaxel Sales and Market Share by Type (2012-2017)
8.1.2 EMEA Paclitaxel Revenue and Market Share by Type (2012-2017)
8.2 Natural Paclitaxel Sales Growth and Price
10.2.1 EMEA Natural Paclitaxel Sales Growth (2012-2017)
10.2.2 EMEA Natural Paclitaxel Price (2012-2017)
8.3 Semi-synthetic Paclitaxel Sales Growth and Price
10.3.1 EMEA Semi-synthetic Paclitaxel Sales Growth (2012-2017)
10.3.2 EMEA Semi-synthetic Paclitaxel Price (2012-2017)

9 EMEA Paclitaxel Market Segment by Application
9.1 EMEA Paclitaxel Sales Market Share by Application (2012-2017)
9.2 Ovarian Cancer Sales Growth (2012-2017)
9.3 Cervical Cancer Sales Growth (2012-2017)
9.4 Breast Cancer Sales Growth (2012-2017)
9.5 Other Sales Growth (2012-2017)

10 EMEA Paclitaxel Market Forecast (2017-2022)
10.1 EMEA Paclitaxel Sales, Revenue and Growth Rate (2017-2022)
10.2 Paclitaxel Market Forecast by Regions (2017-2022)
10.2.1 Europe Paclitaxel Market Forecast by Regions (2017-2022)
10.2.1.1 Germany Paclitaxel Sales Forecast 2017-2022
10.2.1.2 France Paclitaxel Sales Forecast 2017-2022
10.2.1.3 UK Paclitaxel Sales Forecast 2017-2022
10.2.1.4 Russia Paclitaxel Sales Forecast 2017-2022
10.2.1.5 Italy Paclitaxel Sales Forecast 2017-2022
10.2.1.6 Turkey Paclitaxel Sales Forecast 2017-2022
10.2.2 Middle East Market Forecast by Regions (2017-2022)
10.2.2.1 Saudi Arabia Paclitaxel Sales Forecast 2017-2022
10.2.2.2 Israel Paclitaxel Sales Forecast 2017-2022
10.2.2.3 UAE Paclitaxel Sales Forecast 2017-2022
10.2.2.4 Iran Paclitaxel Sales Forecast 2017-2022
10.2.3 Africa Market Forecast by Regions (2017-2022)
10.2.3.1 South Africa Paclitaxel Sales Forecast 2017-2022
10.2.3.2 Nigeria Paclitaxel Sales Forecast 2017-2022
10.2.3.3 Egypt Paclitaxel Sales Forecast 2017-2022
10.2.3.4 Algeria Paclitaxel Sales Forecast 2017-2022
10.3 Paclitaxel Market Forecast by Type (2017-2022)
10.4 Paclitaxel Market Forecast by Application (2017-2022)

11 Sales Channel, Distributors, Traders and Dealers
11.1 Sales Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List of Tables and Figures

Figure Paclitaxel Picture
Table Product Specifications of Paclitaxel
Figure EMEA Sales Market Share of Paclitaxel by Types in 2016
Table Paclitaxel Types for Major Manufacturers
Figure Natural Paclitaxel Picture
Figure Semi-synthetic Paclitaxel Picture
Table Paclitaxel Sales Market Share by Applications in 2016
Figure Ovarian Cancer Picture
Figure Cervical Cancer Picture
Figure Breast Cancer Picture
Figure Other Picture
Figure Germany Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure France Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure UK Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Paclitaxel Revenue (Value) and Growth Rate (2012-2022)
Table Phyton Basic Information, Manufacturing Base and Competitors
Table Phyton Paclitaxel Type and Applications
Table Phyton Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table ScinoPharm Basic Information, Manufacturing Base and Competitors
Table ScinoPharm Paclitaxel Type and Applications
Table ScinoPharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novasep Basic Information, Manufacturing Base and Competitors
Table Novasep Paclitaxel Type and Applications
Table Novasep Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Samyang Basic Information, Manufacturing Base and Competitors
Table Samyang Paclitaxel Type and Applications
Table Samyang Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Polymed Basic Information, Manufacturing Base and Competitors
Table Polymed Paclitaxel Type and Applications
Table Polymed Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table TAPI (Teva) Basic Information, Manufacturing Base and Competitors
Table TAPI (Teva) Paclitaxel Type and Applications
Table TAPI (Teva) Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Fresenius-kabi Basic Information, Manufacturing Base and Competitors
Table Fresenius-kabi Paclitaxel Type and Applications
Table Fresenius-kabi Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Southpharma Basic Information, Manufacturing Base and Competitors
Table Southpharma Paclitaxel Type and Applications
Table Southpharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Haiyao Basic Information, Manufacturing Base and Competitors
Table Haiyao Paclitaxel Type and Applications
Table Haiyao Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Huiang biopharma Basic Information, Manufacturing Base and Competitors
Table Huiang biopharma Paclitaxel Type and Applications
Table Huiang biopharma Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Yunnan Hande Basic Information, Manufacturing Base and Competitors
Table Yunnan Hande Paclitaxel Type and Applications
Table Yunnan Hande Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hainan Yew Pharm Basic Information, Manufacturing Base and Competitors
Table Hainan Yew Pharm Paclitaxel Type and Applications
Table Hainan Yew Pharm Paclitaxel Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Paclitaxel Sales by Manufacturer (2016-2017)
Figure EMEA Paclitaxel Sales Market Share by Manufacturer in 2016
Figure EMEA Paclitaxel Sales Market Share by Manufacturer in 2017
Table EMEA Paclitaxel Revenue by Manufacturer (2016-2017)
Figure EMEA Paclitaxel Revenue Market Share by Manufacturer in 2016
Figure EMEA Paclitaxel Revenue Market Share by Manufacturer in 2017
Table EMEA Paclitaxel Price by Manufacturer (2016-2017)
Figure EMEA Paclitaxel Sales and Growth (2012-2017)
Figure EMEA Paclitaxel Revenue and Growth (2012-2017)
Table EMEA Paclitaxel Sales by Regions (2012-2017)
Table EMEA Paclitaxel Sales Market Share by Regions (2012-2017)
Figure EMEA Paclitaxel Sales Market Share by Regions in 2012
Figure EMEA Paclitaxel Sales Market Share by Regions in 2016
Table EMEA Paclitaxel Revenue by Regions (2012-2017)
Table EMEA Paclitaxel Revenue Market Share by Regions (2012-2017)
Figure EMEA Paclitaxel Revenue Market Share by Regions in 2012
Figure EMEA Paclitaxel Revenue Market Share by Regions in 2016
Figure Europe Paclitaxel Sales and Growth (2012-2017)
Figure Middle East Paclitaxel Sales and Growth (2012-2017)
Figure Africa Paclitaxel Sales and Growth (2012-2017)
Figure Europe Paclitaxel Revenue and Growth (2012-2017)
Table Europe Paclitaxel Sales by Countries (2012-2017)
Table Europe Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Europe Paclitaxel Sales Market Share by Countries in 2012
Figure Europe Paclitaxel Sales Market Share by Countries in 2016
Table Europe Paclitaxel Revenue by Countries (2012-2017)
Table Europe Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Europe Paclitaxel Revenue Market Share by Countries in 2012
Figure Europe Paclitaxel Revenue Market Share by Countries in 2016
Figure Germany Paclitaxel Sales and Growth (2012-2017)
Figure France Paclitaxel Sales and Growth (2012-2017)
Figure UK Paclitaxel Sales and Growth (2012-2017)
Figure Russia Paclitaxel Sales and Growth (2012-2017)
Figure Italy Paclitaxel Sales and Growth (2012-2017)
Figure Turkey Paclitaxel Sales and Growth (2012-2017)
Table Europe Paclitaxel Sales by Manufacturer (2016-2017)
Figure Europe Paclitaxel Sales Market Share by Manufacturer in 2016
Figure Europe Paclitaxel Sales Market Share by Manufacturer in 2017
Table Europe Paclitaxel Revenue by Manufacturer (2016-2017)
Figure Europe Paclitaxel Revenue Market Share by Manufacturer in 2016
Figure Europe Paclitaxel Revenue Market Share by Manufacturer in 2017
Table Europe Paclitaxel Sales by Type (2012-2017)
Table Europe Paclitaxel Sales Share by Type (2012-2017)
Table Europe Paclitaxel Sales by Application (2012-2017)
Table Europe Paclitaxel Sales Share by Application (2012-2017)
Figure Middle East Paclitaxel Revenue and Growth (2012-2017)
Table Middle East Paclitaxel Sales by Countries (2012-2017)
Table Middle East Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Middle East Paclitaxel Sales Market Share by Countries in 2012
Figure Middle East Paclitaxel Sales Market Share by Countries in 2016
Table Middle East Paclitaxel Revenue by Countries (2012-2017)
Table Middle East Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Middle East Paclitaxel Revenue Market Share by Countries in 2012
Figure Middle East Paclitaxel Revenue Market Share by Countries in 2016
Figure Saudi Arabia Paclitaxel Sales and Growth (2012-2017)
Figure Israel Paclitaxel Sales and Growth (2012-2017)
Figure UAE Paclitaxel Sales and Growth (2012-2017)
Figure Iran Paclitaxel Sales and Growth (2012-2017)
Table Middle East Paclitaxel Sales by Manufacturer (2016-2017)
Figure Middle East Paclitaxel Sales Market Share by Manufacturer in 2016
Figure Middle East Paclitaxel Sales Market Share by Manufacturer in 2017
Table Middle East Paclitaxel Revenue by Manufacturer (2016-2017)
Figure Middle East Paclitaxel Revenue Market Share by Manufacturer in 2016
Figure Middle East Paclitaxel Revenue Market Share by Manufacturer in 2017
Table Middle East Paclitaxel Sales by Type (2012-2017)
Table Middle East Paclitaxel Sales Share by Type (2012-2017)
Table Middle East Paclitaxel Sales by Application (2012-2017)
Table Middle East Paclitaxel Sales Share by Application (2012-2017)
Figure Africa Paclitaxel Revenue and Growth (2012-2017)
Table Africa Paclitaxel Sales by Countries (2012-2017)
Table Africa Paclitaxel Sales Market Share by Countries (2012-2017)
Figure Africa Paclitaxel Sales Market Share by Countries in 2012
Figure Africa Paclitaxel Sales Market Share by Countries in 2016
Table Africa Paclitaxel Revenue by Countries (2012-2017)
Table Africa Paclitaxel Revenue Market Share by Countries (2012-2017)
Figure Africa Paclitaxel Revenue Market Share by Countries in 2012
Figure Africa Paclitaxel Revenue Market Share by Countries in 2016
Figure South Africa Paclitaxel Sales and Growth (2012-2017)
Figure Nigeria Paclitaxel Sales and Growth (2012-2017)
Figure Egypt Paclitaxel Sales and Growth (2012-2017)
Figure Algeria Paclitaxel Sales and Growth (2012-2017)
Table Middle East Paclitaxel Sales by Manufacturer (2016-2017)
Figure Middle East Paclitaxel Sales Market Share by Manufacturer in 2016
Figure Middle East Paclitaxel Sales Market Share by Manufacturer in 2017
Table Middle East Paclitaxel Revenue by Manufacturer (2016-2017)
Figure Middle East Paclitaxel Revenue Market Share by Manufacturer in 2016
Figure Middle East Paclitaxel Revenue Market Share by Manufacturer in 2017
Table Middle East Paclitaxel Sales by Type (2012-2017)
Table Middle East Paclitaxel Sales Share by Type (2012-2017)
Table Middle East Paclitaxel Sales by Application (2012-2017)
Table Middle East Paclitaxel Sales Share by Application (2012-2017)
Table EMEA Paclitaxel Sales by Type (2012-2017)
Table EMEA Paclitaxel Sales Share by Type (2012-2017)
Table EMEA Paclitaxel Revenue by Type (2012-2017)
Table EMEA Paclitaxel Revenue Share by Type (2012-2017)
Figure EMEA Natural Paclitaxel Sales Growth (2012-2017)
Figure EMEA Natural Paclitaxel Price (2012-2017)
Figure EMEA Semi-synthetic Paclitaxel Sales Growth (2012-2017)
Figure EMEA Semi-synthetic Paclitaxel Price (2012-2017)
Table EMEA Paclitaxel Sales by Application (2012-2017)
Table EMEA Paclitaxel Sales Share by Application (2012-2017)
Figure EMEA Ovarian Cancer Sales Growth (2012-2017)
Figure EMEA Cervical Cancer Sales Growth (2012-2017)
Figure EMEA Breast Cancer Sales Growth (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Paclitaxel Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Paclitaxel Sales Forecast by Regions (2017-2022)
Table EMEA Paclitaxel Market Share Forecast by Regions (2017-2022)
Table Europe Paclitaxel Sales Forecast by Regions (2017-2022)
Figure Germany Paclitaxel Sales Forecast 2017-2022
Figure France Paclitaxel Sales Forecast 2017-2022
Figure UK Paclitaxel Sales Forecast 2017-2022
Figure Russia Paclitaxel Sales Forecast 2017-2022
Figure Italy Paclitaxel Sales Forecast 2017-2022
Figure Turkey Paclitaxel Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Paclitaxel Sales Forecast 2017-2022
Figure Israel Paclitaxel Sales Forecast 2017-2022
Figure UAE Paclitaxel Sales Forecast 2017-2022
Figure Iran Paclitaxel Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Paclitaxel Sales Forecast 2017-2022
Figure Nigeria Paclitaxel Sales Forecast 2017-2022
Figure Egypt Paclitaxel Sales Forecast 2017-2022
Figure Algeria Paclitaxel Sales Forecast 2017-2022
Table EMEA Paclitaxel Sales Forecast by Type (2017-2022)
Table EMEA Paclitaxel Market Share Forecast by Type (2017-2022)
Table EMEA Paclitaxel Sales Forecast by Application (2017-2022)
Table EMEA Paclitaxel Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
  • Global Erlotinib Hydrochloride Market Insights, Forecast to 2025
    Published: 15-Aug-2018        Price: US 3900 Onwards        Pages: 99
    This report studies the global market size of Erlotinib Hydrochloride in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Erlotinib Hydrochloride in these regions. This research report categorizes the global Erlotinib Hydrochloride market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, mark......
  • Global and India Cancer Treatment Drugs Market Research by Company, Type & Application 2013-2025
    Published: 15-Aug-2018        Price: US 2000 Onwards        Pages: 120
    Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. Market Segment as follows: By Type - Chemotherapy - Targeted Therapy - Immunotherapy (Biologic Therapy) - Hormonal Therapy - Others By Application - Blood Cancer - Breast Cancer - ......
  • Global Capecitabine Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 14-Aug-2018        Price: US 3480 Onwards        Pages: 134
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Capecitabine Market 2018, Forecast to 2023
    Published: 14-Aug-2018        Price: US 4880 Onwards        Pages: 135
    Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Scope of the Report: This report focuses on the Capecitabine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This......
  • Global and India Capecitabine Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 99
    Summary Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Market Segment as follows: By Type - 500 mg - 150 mg By Application - Breast Cancer - Colorectal cancer - Stomach Cancer ......
  • Global and India Mitomycin C Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 102
    Summary Mitomycin C is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Market Segment as follows: By Type - 2 Mg - 10 Mg - 40 Mg - Others By Application - Cancer Trea......
  • Global and India Erlotinib Hydrochloride Market Research by Company, Type & Application 2013-2025
    Published: 13-Aug-2018        Price: US 2000 Onwards        Pages: 122
    Summary Erlotinib Hydrochloride is an anticancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of non-small cell lung cancer (NSCLC), locally advanced, unresectable or metastatic pancreatic cancer, and several other types of cancer. It is usually given after other cancer medicines have been tried without success. Erlotinib acts on the epidermal growth factor receptor (EGFR), and it works by interfering with the growth of cancer cells ......
  • 2018-2023 Global Cancer Treatment Drugs Consumption Market Report
    Published: 10-Aug-2018        Price: US 4660 Onwards        Pages: 179
    In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Cancer Treatment Drugs market for 2018-2023. Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others. The classification of cancer treatment drugs includes chemotherapy, targeted th......
  • Global Hydroxycarbamide Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 10-Aug-2018        Price: US 3480 Onwards        Pages: 137
    Hydroxycarbamide, also known as hydroxyurea, is a medication used in sickle-cell disease, chronic myelogenous leukemia, cervical cancer, and polycythemia vera. In sickle-cell disease it decreases the number of attacks. It is taken by mouth. Common side effects include bone marrow suppression, fevers, loss of appetite, psychiatric problems, shortness of breath, and headaches. There is also concern that it increases the risk of later cancers. Use during pregnancy is typically harmful to the......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs